WallStreetZenWallStreetZen

NASDAQ: CRON
Cronos Group Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Cronos Group earnings were $70.0M for the trailing 12 months ending Jun 30, 2026, with 216.7% growth year over year. The latest CRON earnings report on Jun 30, 2026 announced Q2 2026 earnings of $32.1M, up 133.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CRON reported annual earnings of -$9.4M, with -123% growth. The next CRON earnings date is Nov 5, 2026.

CRON past earnings growth

How has CRON's earnings growth performed historically?

Company
216.67%
Industry
110.12%
Market
91.74%
CRON's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CRON's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CRON's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CRON earnings history

Current Revenue
$179.1M
Current Earnings
$70.0M
Current Profit Margin
39.1%

CRON Return on Equity

Current Company
6.5%
Current Industry
1.8%
Current Market
30.9%
CRON's Return on Equity (6.5%)... subscribe to Premium to read more.
High Return on Equity Performance

CRON Return on Assets

Current Company
5.9%
Current Industry
3.9%
CRON is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CRON announces earnings.

CRON Return on Capital Employed

Current Company
1.8%
Current Industry
9.6%
CRON has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRON vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CRON$34.57M$69.98M+216.67%$0.19
HROW$11.38M-$37.23MN/A-$0.99
AMPH$192.86M$78.55M+51.23%$1.74
PAHC$233.29M$99.72M+12.92%$2.46
PCRX$118.96M$14.64M-38.63%$0.35
View Top Pharmaceutical Stocks

CRON earnings dates

Next earnings date
Nov 5, 2026

Cronos Group Earnings Reports & History FAQ

What were Cronos Group's earnings last quarter?

On CRON's earnings call on Aug 6, 2026, Cronos Group (NASDAQ: CRON) reported Q2 2026 earnings per share (EPS) of $0.09, up 190% year over year. Total CRON earnings for the quarter were $32.09 million. In the same quarter last year, Cronos Group's earnings per share (EPS) was -$0.10.

If you're new to stock investing, here's how to buy Cronos Group stock.

When does Cronos Group report earnings?

The next CRON earnings call is Nov 5, 2026. Add CRON to your watchlist to be reminded of Cronos Group's next earnings date.

Is Cronos Group profitable or losing money?

As of the last Cronos Group earnings report, Cronos Group is currently profitable. Cronos Group's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $69.98 million, a 278.49% increase year over year.

What was CRON's earnings growth in the past year?

As of Cronos Group's earnings date in Aug 6, 2026, Cronos Group's earnings has grown 216.67% year over year. This is 106.55 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 110.12%. CRON earnings in the past year totalled $69.98 million.

What are Cronos Group's earnings expectations?

The current EPS estimate for Cronos Group's earnings report in Nov 5, 2026 is $0.03.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.